Consistent with Hu's study [8], we also observed that higher gp96 expression associated with shorten overall survival time in all malignant gliomas (grade II-IV) (Figure 2(a)), and the TCGA and CGGA analyses verify the association (Figures 2(b) and 2(c)). The gene discussed is HSP90B1; the disease is malignant glioma.